U.S. Markets closed

ResMed noninvasive ventiliation device cleared by FDA for COPD treatment

The Food and Drug Administration recently cleared ResMed's home variable positive airway pressure device - also known as bilevel PAP - for the treatment of respiratory disorders such as COPD, giving severe COPD sufferers a weapon in the fight to stay out of the hospital. ResMed introduced its VPAP COPD device; it will be sold in the U.S. and because of the FDA's clearance for the treatment of COPD, it will make bilevel therapy more accessible through Medicare's Respiratory Assist Device qualifying guidelines.